GPR65 and bone cancer: Neuronal expression of GPR65 has been shown to increase in murine models of bone cancer pain and following carrageenan- or CFA-induced inflammation, and when siRNA targeting GPR65 is administered to animals before the induction of these models less mechanical hyperalgesia is observed [221,222].